Eli Lilly announces results from VIVID-2 study
Eli Lilly (LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to ...
moneycontrol.com1mon
Vivid Mercant Standalone December 2024 Net Sales at Rs 1.89 crore, up 294.69% Y-o-Y
- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...